about
Combating Tuberculosis Infection: A Forbidding ChallengeInhaled nano- and microparticles for drug deliverySolid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and ApplicationNano-Therapeutics for the Lung: State-of-the-Art and Future PerspectivesNovel formulations for antimicrobial peptidesDelivery of RNAi Therapeutics to the Airways-From Bench to BedsideMetabolic Functions of the Lung, Disorders and Associated PathologiesAdvanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug DeliveryControlled actuation of therapeutic nanoparticles: an update on recent progressDasatinib-loaded albumin nanoparticles possess diminished endothelial cell barrier disruption and retain potent anti-leukemia cell activityPolymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment.Progress and future of in vitro models to study translocation of nanoparticles.Vibrational spectroscopy and imaging for concurrent cellular trafficking of co-localized doxorubicin and deuterated phospholipid vesicles.Polylactic Acid-Lemongrass Essential Oil Nanocapsules with Antimicrobial PropertiesDiverse Applications of Nanomedicine.Receptor-mediated endocytosis of macromolecules and strategy to enhance their transport in alveolar epithelial cells.Aspects of pulmonary drug delivery strategies for infections in cystic fibrosis--where do we stand?Inhalable nanocomposite microparticles: preparation, characterization and factors affecting formulation.Nanotechnology based anti-infectives to fight microbial intrusions.The long and winding road to inhaled TB therapy: not only the bug's fault.Chitosan nanoparticles in drug therapy of infectious and inflammatory diseases.Inflammatory monocyte/macrophage modulation by liposome-entrapped spironolactone ameliorates acute lung injury in miceNew perspectives in nanotherapeutics for chronic respiratory diseases.Chitosan-genipin nanohydrogel as a vehicle for sustained delivery of alpha-1 antitrypsin.Natural Antioxidants as Potential Therapy, and a Promising Role for Melatonin Against Pulmonary Hypertension.Nebulised antibiotherapy: conventional versus nanotechnology-based approaches, is targeting at a nano scale a difficult subject?Primary genotoxicity in the liver following pulmonary exposure to carbon black nanoparticles in mice.Recent advances of controlled drug delivery using microfluidic platforms.Lung Epithelial Cell-Derived Microvesicles Regulate Macrophage Migration via MicroRNA-17/221-Induced Integrin β1 Recycling.Surviving nebulization-induced stress: dexamethasone in pH-sensitive archaeosomes.Towards the Identification of an In Vitro Tool for Assessing the Biological Behavior of Aerosol Supplied Nanomaterials.Exosome-Mediated Small RNA Delivery: A Novel Therapeutic Approach for Inflammatory Lung Responses
P2860
Q26750683-5304F96A-4C7F-42E2-8F4C-EFF488A8F8D4Q26771328-797581B2-ABB9-4564-AF25-D9A2A91C005FQ26778603-24DE32C0-E514-4597-A9FD-34C561BFB324Q26786162-AA49FAE2-72C3-48E0-93A5-9F19471327A2Q26991771-EBC5D488-D9F1-4476-9171-A17ACDEAF9D7Q28067306-BFED6551-0B9B-4C5C-A21D-A8959F2AACB9Q28072037-92D09877-492A-433F-BF54-0FE22CA94F05Q28076132-2451EE38-3A1E-4474-BBD9-62BAB87CAF5BQ28077645-BE95F021-246C-4B34-A49C-626F518A9117Q28468632-94EB9D70-E3D9-47B9-8D6C-FFAA212191DFQ33824400-97E203E5-7089-43C5-9426-8AC806ABB8ADQ36001471-BD26ECBB-2785-4E82-8697-35F46C5F9E81Q36904076-5465A310-B987-4118-B4A3-7C437C859034Q37290819-A9549F06-1522-4A86-BDEB-3E93F0629065Q37728142-535F84E8-3CF8-4E61-92DB-85670B555648Q38286395-815BBAC4-2C50-4AAB-8143-F1D23B942E67Q38340865-22F7CCBE-13F2-4033-99E2-A212B4649E03Q38619134-076B8BC9-3032-4A0B-9D21-8B73F5AC542FQ38645320-B7BE7C03-A173-4F20-9B91-16DE4E12CC59Q38782463-6C04C5DB-8E6E-4610-91A9-FBA1F5912679Q38810516-A1BF54CF-C6D9-4C8D-B93F-DDD31D8BACFDQ39739187-3C7CE855-4242-4D5F-9594-3F6CEF4D298EQ40039105-5B91A68D-5284-4919-81D2-CEE9C7EA3894Q40095457-D0973F2C-9C34-4DB9-84D4-62657E6E97C7Q46183692-8B425DA3-1028-4DAF-A1BA-4B6E888FE8B6Q47122978-99CEDF8C-4CC1-46FC-831F-0E493D7AAA28Q47165165-D06FD313-9460-4705-8FBE-F5D8BD867D93Q47666014-B6A0BCC7-E7E5-420D-8514-D645E4168397Q48182981-36612C65-C593-4BA6-ABD0-F427C1B0AB73Q51227992-D624DBC9-0A37-4325-88F2-0CB3D57077DDQ51732567-DB9D7FEF-871B-42E7-8C68-90B9B7D388FFQ57160827-301E98F5-3A8C-438D-9427-2260EC930B04
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Nanoparticle-mediated pulmonary drug delivery: a review
@en
type
label
Nanoparticle-mediated pulmonary drug delivery: a review
@en
prefLabel
Nanoparticle-mediated pulmonary drug delivery: a review
@en
P2860
P921
P356
P1476
Nanoparticle-mediated pulmonary drug delivery: a review
@en
P2093
Christel C Müller-Goymann
Mukta Paranjpe
P2860
P304
P356
10.3390/IJMS15045852
P407
P5008
P577
2014-04-08T00:00:00Z